[Value and action of cytostatics in malignant lymphatic system diseases].
H
H
FLEISCHHACKER
A
A
STACHER
D000818:Animals; D000970:Antineoplastic Agents / Q000628:therapy*; D054697:Cytostatic Agents; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D007938:Leukemia; D007945:Leukemia, Lymphoid / Q000628:therapy*; D008208:Lymphatic System; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D012509:Sarcoma
D000970:Antineoplastic Agents; D054697:Cytostatic Agents
ANTINEOPLASTIC AGENTS/therapy; HODGKIN'S DISEASE/therapy; LEUKEMIA, LYMPHOCYTIC/therapy; LYMPHOSARCOMA/therapy; SARCOMA, RETICULUM CELL/therapy